mH2A1 suppresses enzymatic activity of VRK1 during interphase

被引：0
|
作者：
Kim, W. [1 ]
Kang, T. H. [1 ]
Kim, S. [1 ]
Jeong, M. W. [1 ]
Park, C. H. [1 ]
Choi, Y. H. [1 ]
Woo, K. C. [1 ]
Park, Y. S. [1 ]
Lee, K. H. [1 ]
Kim, D. Y. [1 ]
Kim, K. T. [1 ]
机构：
[1] Postech, Life Sci, Pohang, South Korea
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase
    Kim, Wanil
    Chakraborty, Goutam
    Kim, Sangjune
    Shin, Joon
    Park, Choon-Ho
    Jeong, Min-Woo
    Bharatham, Nagakumar
    Yoon, Ho Sup
    Kim, Kyong-Tai
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) : 5278 - 5289
  • [2] Synthetic lethality of VRK1 in VRK2-methylated cancers
    So, Jonathan
    Mabe, Nathaniel
    Englinger, Bernhard
    Kwon, Jason
    Shim, Brian
    Filbin, Mariella
    Stegmaier, Kimberly
    Hahn, William
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Structural insights into the VRK1-mediated histone phosphorylation and its regulation by mH2A1, a histone H2A variant
    Yoon, Ho Sup
    Shin, Joon
    Chakraborty, Goutam
    FASEB JOURNAL, 2013, 27
  • [4] Downregulation of VRK1 reduces the expression of BANF1 and suppresses the proliferative and migratory activity of esophageal cancer cells
    Ren, Zhenzhen
    Geng, Jie
    Xiong, Chao
    Li, Xuebing
    Li, Yuqing
    Li, Jin
    Liu, Hongchun
    ONCOLOGY LETTERS, 2020, 20 (02) : 1163 - 1170
  • [5] Luteolin suppresses Ovarian Cancer progression via decrease the expression of VRK1
    Chang, Xuboya
    Kajiyama, Hiroaki
    Yoshikawa, Nobuhisa
    Yokoi, Akira
    Tamauchi, Satoshi
    Yoshihara, Masato
    CANCER SCIENCE, 2021, 112 : 770 - 770
  • [6] VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
    Elena Martín-Doncel
    Ana M. Rojas
    Lara Cantarero
    Pedro A. Lazo
    Scientific Reports, 9
  • [7] Crosstalk between PLK1 and VRK1
    Kim, S. -H.
    Jeong, M. -W.
    Choi, Y. -H.
    Park, C. -H.
    Kim, W. -I.
    Kim, S-J.
    Song, H. -J.
    Kim, J. -H.
    Lee, D. -H.
    Jeong, Y. -H.
    Lim, J. -K.
    Kim, Y. -S.
    Kim, K. -T.
    FEBS JOURNAL, 2011, 278 : 385 - 385
  • [8] VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
    Martin-Doncel, Elena
    Rojas, Ana M.
    Cantarero, Lara
    Lazo, Pedro A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2
    Vazquez-Cedeira, Marta
    Barcia-Sanjurjo, Iria
    Sanz-Garcia, Marta
    Barcia, Ramiro
    Lazo, Pedro A.
    PLOS ONE, 2011, 6 (08):
  • [10] VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma
    Shields, Julie A.
    Meier, Samuel R.
    Bandi, Madhavi
    Mulkearns-Hubert, Erin E.
    Hajdari, Nicole
    Ferdinez, Maria Dam
    Engel, Justin L.
    Silver, Daniel J.
    Shen, Binzhang
    Zhang, Wenhai
    Hubert, Christopher G.
    Mitchell, Kelly
    Shakya, Sajina
    Zhao, Shan-Chuan
    Bejnood, Alborz
    Zhang, Minjie
    Sjin, Robert Tjin Tham
    Wilker, Erik
    Lathia, Justin D.
    Andersen, Jannik N.
    Chen, Yingnan
    Li, Fang
    Weber, Barbara
    Huang, Alan
    Emmanuel, Natasha
    CANCER RESEARCH, 2022, 82 (21) : 4044 - 4057
12345